PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 102 filers reported holding PROVENTION BIO INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $733,749 | +132.6% | 30,446 | +2.0% | 0.01% | +150.0% |
| Q4 2022 | $315,409 | +150.3% | 29,840 | +6.5% | 0.00% | +100.0% |
| Q3 2022 | $126,000 | +20.0% | 28,011 | +6.9% | 0.00% | 0.0% |
| Q2 2022 | $105,000 | -48.0% | 26,196 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $202,000 | +21.7% | 27,536 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $166,000 | -14.4% | 29,473 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $194,000 | -26.0% | 30,355 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $262,000 | -19.4% | 31,077 | +0.5% | 0.00% | 0.0% |
| Q1 2021 | $325,000 | -30.7% | 30,926 | +11.8% | 0.00% | -50.0% |
| Q4 2020 | $469,000 | +28.5% | 27,670 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $365,000 | -0.3% | 28,463 | +9.8% | 0.00% | 0.0% |
| Q2 2020 | $366,000 | – | 25,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |